NHS

AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has recommended Imfinzi (durvalumab) in combination with gemcitabine and cisplatin (chemotherapy) for NHS use in England and Wales for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC).1 There remains a significant unmet need for new […]

Global health science solutions company Revvity, PerkinElmer’s Life Science and Diagnostics business’ new name and branding, has announced the establishment of a Scientific Centre of Excellence in Cambridge, UK.   Focused on driving genomic insights to accelerate therapeutic discovery, Revvity’s Scientific Centre of Excellence supports the company’s aim to expand boundaries in pursuit of a ‘better […]

A cancer patient died and three others were hospitalised in the UK after they were administered an unlicensed version of chemotherapy cabazitaxel. According to The Guardian, which reported on the incident, the problem was caused by an issue at private healthcare company Sciensus’ medicines manufacturing unit. In a statement, Sciensus said that it was an […]

The UK spends less on medicines, has a lower adoption of new drugs and poorer health outcomes compared to other similar countries, according to a new report. The King’s Fund report, commissioned by the Association of the British Pharmaceutical Industry (ABPI), gives the UK’s NHS a mixed bill of health across a range of outcome […]

Collaborative working between the NHS and industry could reduce variations in uptake of innovative treatments across the UK, a joint report from NHS Confederation and ABPI argues.   Analysis from the report has shown a significant variation in access to innovative medicines for patients across the UK and showed that uptake of new treatments in these […]

Recently, DDW reported on how over three million people have been invited to join Our Future Health. Andrew Roddam, CEO of Our Future Health, shares the impact research programmes such as this will have on drug discovery.  Millions of people in the UK and around the world spend many years of their later life in […]

Over three million people have been invited to join Our Future Health, which is set to become the UK’s largest ever health research programme. Letters are being sent out this autumn inviting members of the public to join Our Future Health, designed to help develop new ways to prevent, detect and treat diseases. Eventually, up […]